{"id":"https://openalex.org/W4361833476","doi":"https://doi.org/10.1158/0008-5472.22393811","title":"Supplementary Figure 1 from NF-\u03baB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells","display_name":"Supplementary Figure 1 from NF-\u03baB Hyperactivation in Tumor Tissues Allows Tumor-Selective Reprogramming of the Chemokine Microenvironment to Enhance the Recruitment of Cytolytic T Effector Cells","publication_year":2023,"publication_date":"2023-03-30","ids":{"openalex":"https://openalex.org/W4361833476","doi":"https://doi.org/10.1158/0008-5472.22393811"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.22393811","doi":"https://doi.org/10.1158/0008-5472.22393811","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22393811","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NF-_B_Hyperactivation_in_Tumor_Tissues_Allows_Tumor-Selective_Reprogramming_of_the_Chemokine_Microenvironment_to_Enhance_the_Recruitment_of_Cytolytic_T_Effector_Cells/22393811/1/files/39839399.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NF-_B_Hyperactivation_in_Tumor_Tissues_Allows_Tumor-Selective_Reprogramming_of_the_Chemokine_Microenvironment_to_Enhance_the_Recruitment_of_Cytolytic_T_Effector_Cells/22393811/1/files/39839399.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041622940","display_name":"Ravikumar Muthuswamy","orcid":"https://orcid.org/0000-0002-1579-1664","observed_orcids":["https://orcid.org/0000-0002-1579-1664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravikumar Muthuswamy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032783217","display_name":"Erik Berk","orcid":"https://orcid.org/0000-0001-5980-1329","observed_orcids":["https://orcid.org/0000-0001-5980-1329"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erik Berk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112888032","display_name":"Beth A. Fallert Junecko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beth Fallert Junecko","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073859061","display_name":"Herbert J. Zeh","orcid":"https://orcid.org/0000-0003-2017-1934","observed_orcids":["https://orcid.org/0000-0003-2017-1934"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herbert J. Zeh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052559700","display_name":"Amer H. Zureikat","orcid":"https://orcid.org/0000-0002-7800-5464","observed_orcids":["https://orcid.org/0000-0002-7800-5464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amer H. Zureikat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056886978","display_name":"Daniel Paul Normolle","orcid":"https://orcid.org/0000-0001-8675-5014","observed_orcids":["https://orcid.org/0000-0001-8675-5014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Normolle","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016086038","display_name":"The Minh Luong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"The Minh Luong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057033838","display_name":"Todd A. Reinhart","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Todd A. Reinhart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113437665","display_name":"David L. Bartlett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David L. Bartlett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5057788524","display_name":"Pawe\u0142 Kali\u0144ski","orcid":"https://orcid.org/0000-0001-7025-3562","observed_orcids":["https://orcid.org/0000-0001-7025-3562"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pawel Kalinski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4011000096797943,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4011000096797943,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11591","display_name":"NF-\u03baB Signaling Pathways","score":0.34470000863075256,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.051500000059604645,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8809999823570251},{"id":"https://openalex.org/keywords/t-cell-recruitment","display_name":"T cell recruitment","score":0.9010000228881836}],"concepts":[{"id":"https://openalex.org/C77255625","wikidata":"https://www.wikidata.org/wiki/Q402093","display_name":"Reprogramming","level":3,"score":0.790859043598175},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.7387690544128418},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.6448001861572266},{"id":"https://openalex.org/C73588182","wikidata":"https://www.wikidata.org/wiki/Q2663023","display_name":"Cytolysis","level":4,"score":0.6203894019126892},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5956641435623169},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5388611555099487},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4578271508216858},{"id":"https://openalex.org/C2778366672","wikidata":"https://www.wikidata.org/wiki/Q5957687","display_name":"Hyperactivation","level":2,"score":0.4297511577606201},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42589902877807617},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.42238712310791016},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35340142250061035},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3408289849758148},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.1707799732685089},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.16096198558807373},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.10955747961997986},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.10507449507713318},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.09236812591552734}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/0008-5472.22393811","doi":"https://doi.org/10.1158/0008-5472.22393811","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22393811","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NF-_B_Hyperactivation_in_Tumor_Tissues_Allows_Tumor-Selective_Reprogramming_of_the_Chemokine_Microenvironment_to_Enhance_the_Recruitment_of_Cytolytic_T_Effector_Cells/22393811/1/files/39839399.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/0008-5472.22393811.v1","doi":"https://doi.org/10.1158/0008-5472.22393811.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.22393811.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22393811","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NF-_B_Hyperactivation_in_Tumor_Tissues_Allows_Tumor-Selective_Reprogramming_of_the_Chemokine_Microenvironment_to_Enhance_the_Recruitment_of_Cytolytic_T_Effector_Cells/22393811","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.22393811","doi":"https://doi.org/10.1158/0008-5472.22393811","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/0008-5472.22393811","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_NF-_B_Hyperactivation_in_Tumor_Tissues_Allows_Tumor-Selective_Reprogramming_of_the_Chemokine_Microenvironment_to_Enhance_the_Recruitment_of_Cytolytic_T_Effector_Cells/22393811/1/files/39839399.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361833476.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2002293894","https://openalex.org/W4392725691","https://openalex.org/W2776435182","https://openalex.org/W4416449632","https://openalex.org/W155684147","https://openalex.org/W2146818467","https://openalex.org/W837504750","https://openalex.org/W2075937153","https://openalex.org/W4313351353","https://openalex.org/W4362560706"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"191K,":[3],"Processing":[4],"of":[5],"tumors":[6],"and":[7],"marginal":[8],"tissues":[9]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}